Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.
Siderowf
A D
AD
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia 19107, USA.
Holloway
R G
RG
Stern
M B
MB
D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D006801:Humans; D010300:Parkinson Disease / Q000191:economics* / Q000628:therapy; D019057:Quality-Adjusted Life Years; D013673:Technology Assessment, Biomedical / Q000191:economics